$225.46
0.02%
NYSE, Jan 02, 10:00 pm CET

IQVIA Stock price

$225.37
-0.26 0.12% 1M
+60.72 36.88% 6M
-0.04 0.02% YTD
+30.25 15.50% 1Y
+20.48 10.00% 3Y
+48.77 27.62% 5Y
+158.33 236.17% 10Y
+183.26 435.19% 20Y
NYSE, Closing price Fri, Jan 02 2026
-0.04 0.02%

New AI Insights on IQVIA Insights AI Insights on IQVIA

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$38.4b
Enterprise Value
$51.4b
Net debt
$13.0b
Cash
$2.0b
Shares outstanding
170.3m
Valuation (TTM | estimate)
P/E
30.2 | 18.8
P/S
2.4 | 2.3
EV/Sales
3.2 | 3.1
EV/FCF
23.2
P/B
6.2
Financial Health
Equity Ratio
22.6%
Return on Equity
22.6%
ROCE
11.2%
ROIC
9.0%
Debt/Equity
2.4
Financials (TTM | estimate)
Revenue
$15.9b | $16.4b
EBITDA
$3.4b | $3.8b
EBIT
$2.3b | $3.1b
Net Income
$1.3b | $2.0b
Free Cash Flow
$2.2b
Growth (TTM | estimate)
Revenue
3.9% | 6.2%
EBITDA
2.9% | 12.9%
EBIT
4.3% | 37.5%
Net Income
-8.7% | 48.9%
Free Cash Flow
12.8%
Margin (TTM | estimate)
Gross
33.8%
EBITDA
21.3% | 23.4%
EBIT
14.2%
Net
8.1% | 12.5%
Free Cash Flow
13.9%
More
EPS
$7.5
FCF per Share
$13.0
Short interest
3.2%
Employees
88k
Rev per Employee
$180.0k
Show more

Is IQVIA a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

IQVIA Stock Analysis

Unlock Scores for Free

Analyst Opinions

29 Analysts have issued a IQVIA forecast:

24x Buy
83%
5x Hold
17%

Analyst Opinions

29 Analysts have issued a IQVIA forecast:

Buy
83%
Hold
17%

Financial data from IQVIA

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
15,904 15,904
4% 4%
100%
- Direct Costs 10,532 10,532
6% 6%
66%
5,372 5,372
0% 0%
34%
- Selling and Administrative Expenses 1,984 1,984
5% 5%
12%
- Research and Development Expense - -
-
-
3,388 3,388
3% 3%
21%
- Depreciation and Amortization 1,130 1,130
0% 0%
7%
EBIT (Operating Income) EBIT 2,258 2,258
4% 4%
14%
Net Profit 1,283 1,283
9% 9%
8%

In millions USD.

Don't miss a Thing! We will send you all news about IQVIA directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

IQVIA Stock News

Positive
Seeking Alpha
23 days ago
IQVIA Holdings is positioned as the indispensable data and technology backbone of the life sciences industry, far beyond a traditional CRO. Long-term revenue visibility is underpinned by a record $32.4B backlog, technology-driven margin expansion, and robust buyback-enhanced EPS growth. IQV's unique, comprehensive data assets and AI-enabled services create a defensible moat, insulating it from ...
Neutral
Business Wire
about one month ago
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE: IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced a strategic collaboration with Amazon Web Services (AWS), naming AWS as IQVIA's Preferred Agentic Cloud Provider. The partnership, revealed at AWS re:Invent, is a...
Positive
Seeking Alpha
about 2 months ago
Alibaba Group was a contributor during the quarter. The stock price rose significantly following earnings that reflected rapid Chinese AI growth. Alphabet was a contributor during the quarter. The stock price appreciated following a favorable ruling in the Google Search antitrust case and Q2 earnings that exceeded expectations across the board. Charter Communications was a detractor during the ...
More IQVIA News

Company Profile

Provides biopharmaceutical development services and commercial outsourcing services

Head office United States
CEO Ari Bousbib
Employees 88,000
Founded 1950
Website ir.iqvia.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today